• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Modafinil for the Improvement of Patient Outcomes Following Traumatic Brain Injury
Conclusion. Modafinil is a central nervous system stimulant with well-established effectiveness in the treatment of narcolepsy and shift-work sleep disorder. There is conflicting evidence about the benefits of modafinil in the treatment of fatigue and EDS secondary to TBI. One randomized, controlled study states that modafinil does not significantly improve patient wakefulness, while another concludes that modafinil corrects EDS but not fatigue. An observational study provides evidence that modafinil increases alertness in fatigued patients with past medical history of brainstem diencephalic stroke or multiple sclerosis. ...
Source: Innovations in Clinical Neuroscience - April 1, 2018 Category: Neuroscience Authors: ICNS Online Editor Tags: Current Issue Review excessive daytime sleep fatigue head injury modafinil stroke TBI traumatic brain injury Source Type: research

Hillary Clinton's New Platform Is A Blow To Mental Health Stigma
Democratic presidential nominee Hillary Clinton released a wide-ranging mental health plan on Monday, saying that her office would support Americans living with mental health issues through better legislation. “The next generation must grow up knowing that mental health is a key component of overall health and there is no shame, stigma or barriers to seeking out care,” Clinton’s campaign stressed in an announcement. Of course, candidate platforms rarely remain intact if they actually become policy after election day, but Clinton’s focus on normalizing mental health treatment reflects growi...
Source: Healthy Living - The Huffington Post - August 30, 2016 Category: Consumer Health News Source Type: news

UCLA faculty voice: Body mass index perpetuates stigmas and indicates little about health
UCLA A. Janet Tomiyama A. Janet Tomiyama is assistant professor of psychology in the UCLA College. Jeffrey Hunger is a doctoral candidate of psychology at UC Santa Barbara. This op-ed appeared March 7 in Zócalo Public Square. You’ve just returned from your morning run and you’re rustling through your snail mail when you receive some shocking news — an official memo from your employer informing you that your health insurance premium is increasing by 30 percent. You’ve been deemed a health risk, and you are being charged accordingly. Yet you’re the picture of health: A run is part of your daily routine, you passe...
Source: UCLA Newsroom: Health Sciences - April 1, 2016 Category: Universities & Medical Training Source Type: news

Driving Home After A Night Shift Is Way More Scary Than You Thought
Working the night shift is a known health hazard. Scientists theorize that staying awake at night goes against our natural circadian rhythm, the body's internal clock, which is why people who work after hours are more prone to heart attacks, heart disease, diabetes, obesity, stroke and depression.    The drive home after a night shift can be hazardous too, confirms a small but compelling new study involving a global team of researchers from Boston and Australia. They conducted daytime driving tests on a closed driving track among 16 night shift workers who had just come off the job. The study found that the volun...
Source: Science - The Huffington Post - December 23, 2015 Category: Science Source Type: news

Autism in the Son of a Woman with Mitochondrial Myopathy and Dysautonomia: A Case Report
Conclusion Given emerging evidence that mitochondrial dysfunction, particularly in the electron transport chain needed for cellular energy production, is an underlying pathophysiological mechanism for some varieties of ASD, clinicians should have a high index of suspicion for mitochondrial disease, especially when they encounter a patient with unusual neurological or constitutional symptoms. The prevalence of mitochondrial disease in ASD patients may be as high as five percent, which means that it is not the “zebra”[27] diagnosis that it might be in a non-ASD patient, where prevalence is about 0.01 percent.10 Reference...
Source: Innovations in Clinical Neuroscience - October 9, 2015 Category: Neuroscience Authors: ICN Online Editor Tags: Anxiety Disorders Asperger's syndrome Autism Behavioral and Cognitive Neurology Case Report Current Issue Intellectual Disability Neurologic Systems and Symptoms Pervasive Developmental Disorders ASD autism spectrum disorder dysauton Source Type: research